Document Detail


Myocardial infarct size measurement using geometric angle calculation.
MedLine Citation:
PMID:  25266895     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: In basic cardiovascular research focusing on animal models of myocardial infarction (MI), the measurement of infarct size is performed by planimetry of histological sections of the heart. However, in the setting of chronic MI with ongoing changes in ventricular geometry caused by wall thinning and hypertrophy, the scar area tends to become smaller.
MATERIALS AND METHODS: Here, in this study we compared infarct measurements in tissue sections (of rat and porcine hearts) based on three different calculation approaches, that is, infarct area, infarct lengths and infarct angles utilizing the centroid of the left ventricle using a newly developed calculation approach.
RESULTS: Infarct sizes from all three measurement approaches showed significant correlation with parameters of cardiac function. However, results derived from area measurements were significantly smaller than those obtained using the other two measurement approaches due to scar thinning (infarct size area: 14·81% ± 1·27 SEM, length: 23·94% ± 2·04 SEM, angle: 24·75% ± 2·13 SEM, P < 0·0001, n = 30). Moreover, results from angle measurements evidenced a much better correlation with parameters of cardiac function in a small animal model of chronic MI (e.g. ejection fraction, angle: r = -0·73; length: r = -0·64; area: r = -0·59, n = 30) as well as in a large animal model of acute MI (angle: r = -0·82; area: r = -0·67, n = 10).
CONCLUSIONS: We concluded that area-, length- and angle-based measurements can be used to determine the relative infarct size in acute MI models, although an area-based measurement might be less accurate in the setting of chronic MI. Our new method of infarct angle measurement is a reliable and simple way to calculate infarct size compared with conventional measurement approaches.
Authors:
Michael Lichtenauer; Catharina Schreiber; Christian Jung; Lucian Beer; Andreas Mangold; Mariann Gyöngyösi; Bruno Karl Podesser; Hendrik Jan Ankersmit
Related Documents :
22883165 - Frequency of asymptomatic disease among family members with noncompaction cardiomyopathy.
1293445 - Monitoring of respiratory and heart rates using a fibre-optic sensor.
21989745 - Cardiac amyloidosis: evolving approach to diagnosis and management.
22844395 - Targeted delivery of human vegf gene via complexes of magnetic nanoparticle-adenoviral ...
8059695 - Effects of beta blockers (atenolol or metoprolol) on heart rate variability after acute...
9605055 - Loss of adrenergic control of the force-frequency relation in heart failure secondary t...
Publication Detail:
Type:  Journal Article     Date:  2013-12-19
Journal Detail:
Title:  European journal of clinical investigation     Volume:  44     ISSN:  1365-2362     ISO Abbreviation:  Eur. J. Clin. Invest.     Publication Date:  2014 Feb 
Date Detail:
Created Date:  2014-09-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0245331     Medline TA:  Eur J Clin Invest     Country:  England    
Other Details:
Languages:  eng     Pagination:  160-7     Citation Subset:  IM    
Copyright Information:
© 2013 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cholecystectomy in octogenarians: be careful.
Next Document:  Epigenetic DNA Methylation of Antioxidative Stress Regulator NRF2 in Human Prostate Cancer.